PF-06700841
Sponsors
Pfizer, Emma Guttman
Conditions
Acne InversaAlopecia AreataAtopic DermatitisChronic Plaque PsoriasisCicatricial AlopeciaCrohn's DiseaseHealthyHealthy Female Volunteers
Phase 1
Safety and Pharmacokinetic Study of PF-06700841 in Japanese Healthy Volunteers
CompletedNCT03236493
Start: 2017-08-16End: 2017-10-12Updated: 2017-10-25
A Study to Evaluate the PF-06700841 Effect on QTc Interval in Healthy Volunteers
CompletedNCT03656952
Start: 2018-09-05End: 2019-02-06Updated: 2019-02-27
A Study to Investigate the Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of PF-06700841 in Healthy Participants
CompletedNCT04090047
Start: 2019-09-24End: 2019-12-19Updated: 2020-01-30
Renal Impairment Study of PF-06700841
CompletedNCT04260464
Start: 2020-07-03End: 2022-05-04Updated: 2024-01-22
Effect Of Multiple Dose PF-06700841 On The Pharmacokinetics Of Single Dose Oral Contraceptive Steroids
CompletedNCT04267250
Start: 2020-08-24End: 2020-11-06Updated: 2020-11-13
Phase 2
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis
CompletedNCT02958865
Start: 2017-02-03End: 2021-05-10Updated: 2022-07-21
Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis
CompletedNCT02969018
Start: 2016-12-31End: 2018-03-31Updated: 2019-03-29
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
CompletedNCT02974868
Start: 2016-12-15End: 2019-05-15Updated: 2020-05-26
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease
CompletedNCT03395184
Start: 2018-02-02End: 2023-10-19Updated: 2024-10-30
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
CompletedNCT03850483
Start: 2019-04-08End: 2021-04-20Updated: 2022-06-29
Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis
CompletedNCT03903822
Start: 2019-05-13End: 2020-05-07Updated: 2021-03-29
A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis
CompletedNCT03963401
Start: 2019-06-13End: 2021-01-15Updated: 2021-08-04
A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa
CompletedNCT04092452
Start: 2019-12-02End: 2022-01-10Updated: 2023-06-15
Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia
CompletedNCT05076006
Start: 2021-05-19End: 2023-09-30Updated: 2024-07-15
Related Papers
4 more papers not shown